PROGYNY INC

PGNY Healthcare
$16.60
Market Cap $1.36B
P/E Ratio 25.54
Forward P/E 7.90
Dividend Yield —
Beta 0.99
52W Range $16.60 - $28.42
# Hedge Funds 2
Sector Healthcare
Industry Healthcare Plans

Hedge Fund Ownership

2 funds holding this stock
Investor 2 % of Portfolio i Weight of this stock in the investor's portfolio Value i Total dollar value of the position Shares i Number of shares held Activity i Portfolio change type: New, Increased, Decreased, or Sold
First Eagle Investment Management First Eagle Investment Management 0.01% $5.46M 212,612 Add 40.15%
Robert Olstein Olstein Capital Management 0.00% $0 36,000 Add 2.86%

Insider Trading

14 transactions in the last 6 months
Insider i Name of the company insider who made the trade 14 Type i Purchase (buy) or Sale (sell) Shares i Number of shares traded Price i Price per share at time of transaction Value i Total dollar value of the transaction Trade Date i Date the transaction was executed Filing Date i Date the SEC filing was submitted
Swartz AllisonEVP, GCSale599$17.54$10.51K04 Mar 202606 Mar 2026
Allison SwartzEVP, GCSale599$17.54$10.51K04 Mar 202606 Mar 2026
Swartz AllisonEVP, GCSale4,157$17.40$72.33K03 Mar 202604 Mar 2026
Swartz AllisonEVP, GCSale500$17.40$8.70K03 Mar 202604 Mar 2026
Swartz AllisonEVP, GCSale2,199$17.27$37.98K02 Mar 202604 Mar 2026
Livingston Mark S.CHIEF FINANCIAL OFFICERSale459$25.50$11.70K11 Dec 202515 Dec 2025
Swartz AllisonEVP, GCSale530$24.59$13.03K04 Dec 202508 Dec 2025
Livingston Mark S.CHIEF FINANCIAL OFFICERSale213$25.50$5.43K02 Dec 202504 Dec 2025
Mark S. LivingstonCHIEF FINANCIAL OFFICERSale213$25.50$5.43K02 Dec 202504 Dec 2025
Swartz AllisonEVP, GCSale2,398$26.87$64.43K28 Nov 202502 Dec 2025
Allison SwartzEVP, GCSale2,398$26.87$64.43K28 Nov 202502 Dec 2025
Livingston Mark S.CHIEF FINANCIAL OFFICERSale21,303$25.50$543.23K17 Nov 202519 Nov 2025
Mark S. LivingstonCHIEF FINANCIAL OFFICERSale21,303$25.50$543.23K17 Nov 202519 Nov 2025
Anevski PeterCHIEF EXECUTIVE OFFICERBuy79,500$24.29$1.93M13 Nov 202517 Nov 2025

Frequently Asked Questions

What is PGNY stock price today?

PROGYNY INC (PGNY) is currently trading at $16.60. The stock has a 52-week range of $16.60 to $28.42 and a market capitalization of $1.36B.

Is PGNY a good stock to buy in 2026?

PROGYNY INC has a P/E ratio of 25.5 (forward P/E: 7.9), a dividend yield of none, and 1-year performance of -28.3%. 2 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.

Are insiders buying or selling PGNY stock?

There have been 14 insider transactions for PGNY in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.

How has PGNY stock performed over the past year?

PROGYNY INC (PGNY) has returned -28.3% over the past 12 months. The stock traded between $16.60 and $28.42 during this period, and is currently at $16.60.

Which hedge funds own PGNY (PROGYNY INC)?

2 tracked hedge funds currently hold PGNY in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.

What is PGNY's market cap and valuation?

PROGYNY INC (PGNY) has a market capitalization of $1.36B. The trailing P/E ratio is 25.5 and forward P/E is 7.9. The stock is classified in the Healthcare sector.

What is PGNY's revenue and profitability?

PROGYNY INC reported revenue of $1.29B with net income of $58.52M and a profit margin of 0.05%. The stock has a beta of 0.99.

What sector is PGNY in and who are its biggest institutional holders?

PROGYNY INC (PGNY) operates in the Healthcare sector. It is held by 2 tracked hedge funds. See the ownership table above for the complete list.